PAIGE MACKENZIE: Open Payments
NPI 1437703592 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 29 payments from 13 companies in 2025. Trend: 2023 $447 · 2024 $775 · 2025 $749
Food & beverage: $717Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $195 |
| ABBVIE INC. | 6 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Celltrion USA Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $38 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Ardelyx, Inc. | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
Products named: Wegovy, VEGZELMA, ENTYVIO, TREMFYA, SKYRIZI, CREON, VOQUEZNA, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
